Abundant CD8+ tumor infiltrating lymphocytes and beta-2-microglobulin are associated with better outcome and response to interleukin-2 therapy in advanced stage clear cell renal cell carcinoma

Dale Davis, Maria S. Tretiakova, Chris Kizzar, Randy Woltjer, Victoria Krajbich, Scott S. Tykodi, Christian Lanciault, Nicole K. Andeen

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Abundant CD8+ tumor infiltrating lymphocytes and beta-2-microglobulin are associated with better outcome and response to interleukin-2 therapy in advanced stage clear cell renal cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences